Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.29, read 2026-10-28
Ethical does not pass the values gate
Price2.99 USD
Fair value2.28
Ethical score70.0/100
Our investment reviews on this name
2026-10-29Read Distribution2.99+0.0% to today Markup gives way to Distribution after a 14% rise in 10 weeks
2026-08-21Read Markup2.63+13.7% to today ✓Distribution gives way to Markup after a 12% rise in 7 weeks
2026-07-02Read Distribution2.34+27.8% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
AMC Entertainment Holdings, Inc. holds its Distribution at $2.99. The statistical read favours the sellers, held for 44 days.
As held on the ledger · 2026-10-28
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 44 days
Price at the screen
$2.99
Valuation
N/A trailing · 36.63 forward price to earnings
Values screen
FAIL· score 70.0
Beta
2.17
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
101.47%
Below 33%
Interest-bearing debt is 101.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
6.53%
Below 49%
Money owed to the company is 6.5% of assets, under the 49% limit.
Pass
Revenue purity
0.16%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
AMC Entertainment Holdings,'s business is in a permissible area, but its interest-bearing debt is about 101% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when AMC's ethical verdict changes
Today AMC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. The price runs 23.7% above the base estimate.
Third-party analyst targets: 6 covering, consensus Hold. The average target sits +5% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AMC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 51% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markup$2.93+0.0%Entry 24
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 51% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markup$2.93+0.0%Entry 23
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 51% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$2.93+0.0%Entry 22
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 51% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$2.93+0.0%Entry 21
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$2.93+0.0%Entry 20
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup$2.93-3.0%Entry 19
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markup$3.02+0.0%Entry 18
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markup$3.02+0.0%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markup$3.02+0.0%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (6 analysts) rates it hold, with a mean price target of $2. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.